[HTML][HTML] Safety and Efficacy of Compression Therapy to Prevent Chemotherapy-Induced Peripheral Neuropathy in Lower Extremities of Breast Cancer Patients: A Pilot …
M Okazaki, H Bando, A Terasaki, A Ueda… - Cureus, 2024 - ncbi.nlm.nih.gov
Background Chemotherapy-induced peripheral neuropathy (CIPN) is a problematic adverse
event for breast cancer patients receiving taxane antimitotic agents. We evaluated the …
event for breast cancer patients receiving taxane antimitotic agents. We evaluated the …
[PDF][PDF] Safety and Efficacy of Compression Therapy to Prevent Chemotherapy-Induced Peripheral Neuropathy in Lower Extremities of Breast Cancer Patients: A Pilot …
M Okazaki, H Bando, A Terasaki, A Ueda… - 2024 - assets.cureus.com
Background Chemotherapy-induced peripheral neuropathy (CIPN) is a problematic adverse
event for breast cancer patients receiving taxane antimitotic agents. We evaluated the …
event for breast cancer patients receiving taxane antimitotic agents. We evaluated the …